Charles S. Fuchs

Charles S. Fuchs is an American oncologist. He is director of the Yale Cancer Center in New Haven, Connecticut, and is also Sackler professor of medicine at the Yale School of Medicine[1] and physician-in-chief of the Smilow Cancer Hospital.[2] He has an MD from Harvard Medical School (1986) and an MPH from Harvard School of Public Health (1994). He was a resident at Brigham and Women’s Hospital from 1987 to 1993.[3]

Charles S. Fuchs

He has worked on gastrointestinal cancers and on cancer epidemiology,[4] and has published results of research on colorectal cancer.[5][6]

References

1. "Fuchs to lead Cancer Center". yaledailynews.com.
2. "Charles S. Fuchs, MD, MPH, to Lead Yale Cancer Center and Smilow Cancer Hospital".
3. "Charles S. Fuchs, MD, MPH - DFCI Master Class".
4. "Charles S. Fuchs, MD, MPH | Giants of Cancer Care". www.giantsofcancercare.com.
5. "Comprehensive molecular characterization of human colon and rectal cancer". Nature. 487 (7407): 330–7. July 2012. doi:10.1038/nature11252. PMC 3401966. PMID 22810696.
6. Goldberg RM, Sargent DJ, Morton RF, Fuchs CS, Ramanathan RK, Williamson SK, Findlay BP, Pitot HC, Alberts SR (January 2004). "A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer". J. Clin. Oncol. 22 (1): 23–30. doi:10.1200/JCO.2004.09.046. PMID 14665611.